nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Tapentadol—Rivastigmine—Alzheimer's disease	0.793	1	CrCrCtD
Phenylephrine—MAOA—locus ceruleus—Alzheimer's disease	0.00776	0.314	CbGeAlD
Phenylephrine—Trembling—Rivastigmine—Alzheimer's disease	0.00668	0.0589	CcSEcCtD
Phenylephrine—Epigastric pain—Donepezil—Alzheimer's disease	0.0027	0.0238	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Galantamine—Alzheimer's disease	0.00209	0.0185	CcSEcCtD
Phenylephrine—Atrioventricular block—Galantamine—Alzheimer's disease	0.00174	0.0153	CcSEcCtD
Phenylephrine—Edrophonium—ACHE—Alzheimer's disease	0.00171	0.383	CrCbGaD
Phenylephrine—ADRA1D—forebrain—Alzheimer's disease	0.00169	0.0684	CbGeAlD
Phenylephrine—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.0016	0.0141	CcSEcCtD
Phenylephrine—ADRA1D—telencephalon—Alzheimer's disease	0.00155	0.0629	CbGeAlD
Phenylephrine—Eye irritation—Donepezil—Alzheimer's disease	0.00153	0.0135	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Donepezil—Alzheimer's disease	0.00144	0.0127	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.00144	0.0127	CcSEcCtD
Phenylephrine—Stinging—Rivastigmine—Alzheimer's disease	0.00143	0.0126	CcSEcCtD
Phenylephrine—Pallor—Memantine—Alzheimer's disease	0.00143	0.0126	CcSEcCtD
Phenylephrine—Extrasystoles—Memantine—Alzheimer's disease	0.00141	0.0124	CcSEcCtD
Phenylephrine—Pallor—Rivastigmine—Alzheimer's disease	0.0014	0.0123	CcSEcCtD
Phenylephrine—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00138	0.0121	CcSEcCtD
Phenylephrine—Atrioventricular block—Donepezil—Alzheimer's disease	0.00135	0.0119	CcSEcCtD
Phenylephrine—Atrioventricular block—Memantine—Alzheimer's disease	0.00122	0.0108	CcSEcCtD
Phenylephrine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00119	0.0105	CcSEcCtD
Phenylephrine—Skin exfoliation—Memantine—Alzheimer's disease	0.00113	0.00996	CcSEcCtD
Phenylephrine—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00112	0.00983	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00112	0.00983	CcSEcCtD
Phenylephrine—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00111	0.00975	CcSEcCtD
Phenylephrine—MAOA—embryo—Alzheimer's disease	0.00109	0.044	CbGeAlD
Phenylephrine—Pulmonary oedema—Memantine—Alzheimer's disease	0.00105	0.00929	CcSEcCtD
Phenylephrine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00103	0.00909	CcSEcCtD
Phenylephrine—Edrophonium—BCHE—Alzheimer's disease	0.001	0.225	CrCbGaD
Phenylephrine—ADRA1A—forebrain—Alzheimer's disease	0.000969	0.0393	CbGeAlD
Phenylephrine—MAOA—forebrain—Alzheimer's disease	0.000961	0.0389	CbGeAlD
Phenylephrine—Eye pain—Memantine—Alzheimer's disease	0.000953	0.00839	CcSEcCtD
Phenylephrine—ADRA1B—nervous system—Alzheimer's disease	0.000937	0.0379	CbGeAlD
Phenylephrine—Eye pain—Rivastigmine—Alzheimer's disease	0.000932	0.00821	CcSEcCtD
Phenylephrine—ADRA1D—nervous system—Alzheimer's disease	0.000916	0.0371	CbGeAlD
Phenylephrine—ADRA1B—central nervous system—Alzheimer's disease	0.000902	0.0365	CbGeAlD
Phenylephrine—ADRA1A—telencephalon—Alzheimer's disease	0.000891	0.0361	CbGeAlD
Phenylephrine—MAOA—telencephalon—Alzheimer's disease	0.000883	0.0358	CbGeAlD
Phenylephrine—ADRA1D—central nervous system—Alzheimer's disease	0.000882	0.0357	CbGeAlD
Phenylephrine—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000865	0.00762	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000865	0.00762	CcSEcCtD
Phenylephrine—Bradycardia—Galantamine—Alzheimer's disease	0.000861	0.00758	CcSEcCtD
Phenylephrine—Visual impairment—Galantamine—Alzheimer's disease	0.000815	0.00718	CcSEcCtD
Phenylephrine—Sweating increased—Donepezil—Alzheimer's disease	0.000797	0.00702	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000785	0.00692	CcSEcCtD
Phenylephrine—Cardiac disorder—Galantamine—Alzheimer's disease	0.000785	0.00691	CcSEcCtD
Phenylephrine—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000768	0.00677	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000768	0.00677	CcSEcCtD
Phenylephrine—Angiopathy—Galantamine—Alzheimer's disease	0.000767	0.00676	CcSEcCtD
Phenylephrine—Immune system disorder—Galantamine—Alzheimer's disease	0.000764	0.00673	CcSEcCtD
Phenylephrine—Terbutaline—BCHE—Alzheimer's disease	0.00076	0.171	CrCbGaD
Phenylephrine—Arrhythmia—Galantamine—Alzheimer's disease	0.000755	0.00665	CcSEcCtD
Phenylephrine—Mental disorder—Galantamine—Alzheimer's disease	0.000741	0.00653	CcSEcCtD
Phenylephrine—Sweating increased—Memantine—Alzheimer's disease	0.000724	0.00638	CcSEcCtD
Phenylephrine—Tension—Galantamine—Alzheimer's disease	0.000722	0.00636	CcSEcCtD
Phenylephrine—Dysgeusia—Galantamine—Alzheimer's disease	0.000721	0.00635	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00072	0.00634	CcSEcCtD
Phenylephrine—ADRA1B—brain—Alzheimer's disease	0.000716	0.029	CbGeAlD
Phenylephrine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000715	0.0063	CcSEcCtD
Phenylephrine—Nervousness—Galantamine—Alzheimer's disease	0.000715	0.0063	CcSEcCtD
Phenylephrine—Sweating increased—Rivastigmine—Alzheimer's disease	0.000708	0.00624	CcSEcCtD
Phenylephrine—ADRA1D—brain—Alzheimer's disease	0.0007	0.0284	CbGeAlD
Phenylephrine—Vision blurred—Galantamine—Alzheimer's disease	0.000694	0.00611	CcSEcCtD
Phenylephrine—Tremor—Galantamine—Alzheimer's disease	0.00069	0.00607	CcSEcCtD
Phenylephrine—Agitation—Galantamine—Alzheimer's disease	0.000676	0.00596	CcSEcCtD
Phenylephrine—Bradycardia—Donepezil—Alzheimer's disease	0.000667	0.00588	CcSEcCtD
Phenylephrine—Syncope—Galantamine—Alzheimer's disease	0.00066	0.00581	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000653	0.00576	CcSEcCtD
Phenylephrine—Palpitations—Galantamine—Alzheimer's disease	0.00065	0.00573	CcSEcCtD
Phenylephrine—Myocardial infarction—Memantine—Alzheimer's disease	0.00065	0.00572	CcSEcCtD
Phenylephrine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000647	0.0057	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000639	0.00563	CcSEcCtD
Phenylephrine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000636	0.0056	CcSEcCtD
Phenylephrine—Hypertension—Galantamine—Alzheimer's disease	0.000635	0.0056	CcSEcCtD
Phenylephrine—Visual impairment—Donepezil—Alzheimer's disease	0.000631	0.00556	CcSEcCtD
Phenylephrine—Chest pain—Galantamine—Alzheimer's disease	0.000627	0.00552	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000622	0.00548	CcSEcCtD
Phenylephrine—Bradycardia—Memantine—Alzheimer's disease	0.000606	0.00534	CcSEcCtD
Phenylephrine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000593	0.00522	CcSEcCtD
Phenylephrine—Shock—Galantamine—Alzheimer's disease	0.000591	0.00521	CcSEcCtD
Phenylephrine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000589	0.00519	CcSEcCtD
Phenylephrine—Tachycardia—Galantamine—Alzheimer's disease	0.000586	0.00516	CcSEcCtD
Phenylephrine—Arrhythmia—Donepezil—Alzheimer's disease	0.000585	0.00516	CcSEcCtD
Phenylephrine—Skin disorder—Galantamine—Alzheimer's disease	0.000583	0.00514	CcSEcCtD
Phenylephrine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000581	0.00512	CcSEcCtD
Phenylephrine—Mental disorder—Donepezil—Alzheimer's disease	0.000574	0.00506	CcSEcCtD
Phenylephrine—Visual impairment—Memantine—Alzheimer's disease	0.000573	0.00505	CcSEcCtD
Phenylephrine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000561	0.00494	CcSEcCtD
Phenylephrine—Tension—Donepezil—Alzheimer's disease	0.00056	0.00493	CcSEcCtD
Phenylephrine—Dysgeusia—Donepezil—Alzheimer's disease	0.000559	0.00492	CcSEcCtD
Phenylephrine—Nervousness—Donepezil—Alzheimer's disease	0.000554	0.00488	CcSEcCtD
Phenylephrine—Cardiac disorder—Memantine—Alzheimer's disease	0.000552	0.00486	CcSEcCtD
Phenylephrine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00054	0.00476	CcSEcCtD
Phenylephrine—Angiopathy—Memantine—Alzheimer's disease	0.00054	0.00476	CcSEcCtD
Phenylephrine—Paraesthesia—Galantamine—Alzheimer's disease	0.000539	0.00475	CcSEcCtD
Phenylephrine—Vision blurred—Donepezil—Alzheimer's disease	0.000538	0.00474	CcSEcCtD
Phenylephrine—Immune system disorder—Memantine—Alzheimer's disease	0.000537	0.00473	CcSEcCtD
Phenylephrine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000536	0.00472	CcSEcCtD
Phenylephrine—Tremor—Donepezil—Alzheimer's disease	0.000534	0.00471	CcSEcCtD
Phenylephrine—Arrhythmia—Memantine—Alzheimer's disease	0.000531	0.00468	CcSEcCtD
Phenylephrine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000528	0.00465	CcSEcCtD
Phenylephrine—ADRA1A—nervous system—Alzheimer's disease	0.000526	0.0213	CbGeAlD
Phenylephrine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000525	0.00462	CcSEcCtD
Phenylephrine—Agitation—Donepezil—Alzheimer's disease	0.000524	0.00462	CcSEcCtD
Phenylephrine—MAOA—nervous system—Alzheimer's disease	0.000522	0.0211	CbGeAlD
Phenylephrine—Mental disorder—Memantine—Alzheimer's disease	0.000521	0.00459	CcSEcCtD
Phenylephrine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00052	0.00458	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000519	0.00457	CcSEcCtD
Phenylephrine—Syncope—Donepezil—Alzheimer's disease	0.000512	0.00451	CcSEcCtD
Phenylephrine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00051	0.00449	CcSEcCtD
Phenylephrine—Tension—Memantine—Alzheimer's disease	0.000508	0.00448	CcSEcCtD
Phenylephrine—Dysgeusia—Memantine—Alzheimer's disease	0.000507	0.00447	CcSEcCtD
Phenylephrine—ADRA1A—central nervous system—Alzheimer's disease	0.000507	0.0205	CbGeAlD
Phenylephrine—Nervousness—Memantine—Alzheimer's disease	0.000503	0.00443	CcSEcCtD
Phenylephrine—MAOA—central nervous system—Alzheimer's disease	0.000502	0.0203	CbGeAlD
Phenylephrine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000501	0.00442	CcSEcCtD
Phenylephrine—Tension—Rivastigmine—Alzheimer's disease	0.000497	0.00438	CcSEcCtD
Phenylephrine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000496	0.00437	CcSEcCtD
Phenylephrine—ADRA1A—cerebellum—Alzheimer's disease	0.000495	0.0201	CbGeAlD
Phenylephrine—Hypertension—Donepezil—Alzheimer's disease	0.000492	0.00434	CcSEcCtD
Phenylephrine—Nervousness—Rivastigmine—Alzheimer's disease	0.000492	0.00433	CcSEcCtD
Phenylephrine—MAOA—cerebellum—Alzheimer's disease	0.000491	0.0199	CbGeAlD
Phenylephrine—Vision blurred—Memantine—Alzheimer's disease	0.000488	0.0043	CcSEcCtD
Phenylephrine—Chest pain—Donepezil—Alzheimer's disease	0.000486	0.00428	CcSEcCtD
Phenylephrine—Tremor—Memantine—Alzheimer's disease	0.000485	0.00427	CcSEcCtD
Phenylephrine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000478	0.00421	CcSEcCtD
Phenylephrine—Agitation—Memantine—Alzheimer's disease	0.000476	0.00419	CcSEcCtD
Phenylephrine—Tremor—Rivastigmine—Alzheimer's disease	0.000475	0.00418	CcSEcCtD
Phenylephrine—Agitation—Rivastigmine—Alzheimer's disease	0.000466	0.0041	CcSEcCtD
Phenylephrine—Syncope—Memantine—Alzheimer's disease	0.000464	0.00409	CcSEcCtD
Phenylephrine—Shock—Donepezil—Alzheimer's disease	0.000458	0.00403	CcSEcCtD
Phenylephrine—Palpitations—Memantine—Alzheimer's disease	0.000458	0.00403	CcSEcCtD
Phenylephrine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000457	0.00402	CcSEcCtD
Phenylephrine—Loss of consciousness—Memantine—Alzheimer's disease	0.000455	0.00401	CcSEcCtD
Phenylephrine—Syncope—Rivastigmine—Alzheimer's disease	0.000454	0.004	CcSEcCtD
Phenylephrine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00045	0.00396	CcSEcCtD
Phenylephrine—Palpitations—Rivastigmine—Alzheimer's disease	0.000448	0.00394	CcSEcCtD
Phenylephrine—Hypertension—Memantine—Alzheimer's disease	0.000447	0.00394	CcSEcCtD
Phenylephrine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000445	0.00392	CcSEcCtD
Phenylephrine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000443	0.0039	CcSEcCtD
Phenylephrine—Chest pain—Memantine—Alzheimer's disease	0.000441	0.00388	CcSEcCtD
Phenylephrine—Hypertension—Rivastigmine—Alzheimer's disease	0.000437	0.00385	CcSEcCtD
Phenylephrine—Tapentadol—SLC6A4—Alzheimer's disease	0.000433	0.0972	CrCbGaD
Phenylephrine—Chest pain—Rivastigmine—Alzheimer's disease	0.000431	0.0038	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000428	0.00377	CcSEcCtD
Phenylephrine—Paraesthesia—Donepezil—Alzheimer's disease	0.000418	0.00368	CcSEcCtD
Phenylephrine—Shock—Memantine—Alzheimer's disease	0.000416	0.00366	CcSEcCtD
Phenylephrine—Dyspnoea—Donepezil—Alzheimer's disease	0.000415	0.00366	CcSEcCtD
Phenylephrine—Nervous system disorder—Memantine—Alzheimer's disease	0.000415	0.00365	CcSEcCtD
Phenylephrine—Tachycardia—Memantine—Alzheimer's disease	0.000413	0.00363	CcSEcCtD
Phenylephrine—Skin disorder—Memantine—Alzheimer's disease	0.000411	0.00362	CcSEcCtD
Phenylephrine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000409	0.0036	CcSEcCtD
Phenylephrine—Shock—Rivastigmine—Alzheimer's disease	0.000407	0.00358	CcSEcCtD
Phenylephrine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000406	0.00357	CcSEcCtD
Phenylephrine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000404	0.00356	CcSEcCtD
Phenylephrine—ADRA1A—brain—Alzheimer's disease	0.000402	0.0163	CbGeAlD
Phenylephrine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000402	0.00354	CcSEcCtD
Phenylephrine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000402	0.00354	CcSEcCtD
Phenylephrine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.0004	0.00352	CcSEcCtD
Phenylephrine—MAOA—brain—Alzheimer's disease	0.000399	0.0161	CbGeAlD
Phenylephrine—Pain—Donepezil—Alzheimer's disease	0.000398	0.00351	CcSEcCtD
Phenylephrine—Dizziness—Galantamine—Alzheimer's disease	0.000397	0.0035	CcSEcCtD
Phenylephrine—Vomiting—Galantamine—Alzheimer's disease	0.000382	0.00336	CcSEcCtD
Phenylephrine—Paraesthesia—Memantine—Alzheimer's disease	0.00038	0.00334	CcSEcCtD
Phenylephrine—Rash—Galantamine—Alzheimer's disease	0.000379	0.00334	CcSEcCtD
Phenylephrine—Dermatitis—Galantamine—Alzheimer's disease	0.000378	0.00333	CcSEcCtD
Phenylephrine—Dyspnoea—Memantine—Alzheimer's disease	0.000377	0.00332	CcSEcCtD
Phenylephrine—Headache—Galantamine—Alzheimer's disease	0.000376	0.00331	CcSEcCtD
Phenylephrine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000371	0.00327	CcSEcCtD
Phenylephrine—Urticaria—Donepezil—Alzheimer's disease	0.00037	0.00326	CcSEcCtD
Phenylephrine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000369	0.00325	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000365	0.00321	CcSEcCtD
Phenylephrine—Pain—Memantine—Alzheimer's disease	0.000361	0.00318	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000357	0.00314	CcSEcCtD
Phenylephrine—Nausea—Galantamine—Alzheimer's disease	0.000357	0.00314	CcSEcCtD
Phenylephrine—Pain—Rivastigmine—Alzheimer's disease	0.000354	0.00311	CcSEcCtD
Phenylephrine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000343	0.00302	CcSEcCtD
Phenylephrine—Urticaria—Memantine—Alzheimer's disease	0.000336	0.00296	CcSEcCtD
Phenylephrine—Pruritus—Donepezil—Alzheimer's disease	0.000329	0.0029	CcSEcCtD
Phenylephrine—Urticaria—Rivastigmine—Alzheimer's disease	0.000329	0.00289	CcSEcCtD
Phenylephrine—Hypersensitivity—Memantine—Alzheimer's disease	0.000311	0.00274	CcSEcCtD
Phenylephrine—Dizziness—Donepezil—Alzheimer's disease	0.000308	0.00271	CcSEcCtD
Phenylephrine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000305	0.00268	CcSEcCtD
Phenylephrine—Tapentadol—CYP2D6—Alzheimer's disease	0.000304	0.0683	CrCbGaD
Phenylephrine—Pruritus—Memantine—Alzheimer's disease	0.000299	0.00263	CcSEcCtD
Phenylephrine—Vomiting—Donepezil—Alzheimer's disease	0.000296	0.00261	CcSEcCtD
Phenylephrine—Rash—Donepezil—Alzheimer's disease	0.000294	0.00259	CcSEcCtD
Phenylephrine—Dermatitis—Donepezil—Alzheimer's disease	0.000293	0.00258	CcSEcCtD
Phenylephrine—Pruritus—Rivastigmine—Alzheimer's disease	0.000293	0.00258	CcSEcCtD
Phenylephrine—Headache—Donepezil—Alzheimer's disease	0.000292	0.00257	CcSEcCtD
Phenylephrine—Dizziness—Memantine—Alzheimer's disease	0.00028	0.00246	CcSEcCtD
Phenylephrine—Nausea—Donepezil—Alzheimer's disease	0.000277	0.00244	CcSEcCtD
Phenylephrine—Dizziness—Rivastigmine—Alzheimer's disease	0.000273	0.00241	CcSEcCtD
Phenylephrine—Vomiting—Memantine—Alzheimer's disease	0.000269	0.00237	CcSEcCtD
Phenylephrine—Rash—Memantine—Alzheimer's disease	0.000267	0.00235	CcSEcCtD
Phenylephrine—Dermatitis—Memantine—Alzheimer's disease	0.000266	0.00235	CcSEcCtD
Phenylephrine—Headache—Memantine—Alzheimer's disease	0.000265	0.00233	CcSEcCtD
Phenylephrine—Vomiting—Rivastigmine—Alzheimer's disease	0.000263	0.00232	CcSEcCtD
Phenylephrine—Rash—Rivastigmine—Alzheimer's disease	0.000261	0.0023	CcSEcCtD
Phenylephrine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00026	0.00229	CcSEcCtD
Phenylephrine—Headache—Rivastigmine—Alzheimer's disease	0.000259	0.00228	CcSEcCtD
Phenylephrine—Nausea—Memantine—Alzheimer's disease	0.000251	0.00221	CcSEcCtD
Phenylephrine—Epinephrine—TNF—Alzheimer's disease	0.000248	0.0556	CrCbGaD
Phenylephrine—Nausea—Rivastigmine—Alzheimer's disease	0.000246	0.00216	CcSEcCtD
Phenylephrine—ADRA1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.27e-05	0.000354	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP2D6—Alzheimer's disease	2.27e-05	0.000353	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	2.26e-05	0.000352	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GAB2—Alzheimer's disease	2.25e-05	0.000349	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—SST—Alzheimer's disease	2.25e-05	0.000349	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PSEN2—Alzheimer's disease	2.24e-05	0.000349	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LRP1—Alzheimer's disease	2.23e-05	0.000347	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—APP—Alzheimer's disease	2.19e-05	0.00034	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GAL—Alzheimer's disease	2.18e-05	0.000339	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GFAP—Alzheimer's disease	2.18e-05	0.000339	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CCR5—Alzheimer's disease	2.16e-05	0.000336	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CCL2—Alzheimer's disease	2.16e-05	0.000335	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—BCHE—Alzheimer's disease	2.15e-05	0.000334	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	2.14e-05	0.000333	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PSENEN—Alzheimer's disease	2.12e-05	0.000329	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.12e-05	0.000329	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APH1A—Alzheimer's disease	2.09e-05	0.000325	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PRKCG—Alzheimer's disease	2.07e-05	0.000322	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PLCB1—Alzheimer's disease	2.07e-05	0.000321	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NPY—Alzheimer's disease	2.06e-05	0.000321	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IAPP—Alzheimer's disease	2.05e-05	0.000319	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PLD3—Alzheimer's disease	2.04e-05	0.000318	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.04e-05	0.000318	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NCSTN—Alzheimer's disease	2.03e-05	0.000316	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PLCB1—Alzheimer's disease	2.03e-05	0.000316	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.02e-05	0.000314	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CRH—Alzheimer's disease	1.99e-05	0.00031	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LRP1—Alzheimer's disease	1.98e-05	0.000308	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ABCA1—Alzheimer's disease	1.97e-05	0.000306	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCR5—Alzheimer's disease	1.96e-05	0.000305	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.96e-05	0.000305	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GAL—Alzheimer's disease	1.94e-05	0.000301	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GFAP—Alzheimer's disease	1.94e-05	0.000301	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2A—Alzheimer's disease	1.92e-05	0.000299	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—A2M—Alzheimer's disease	1.92e-05	0.000299	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.92e-05	0.000298	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.91e-05	0.000297	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.89e-05	0.000295	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.89e-05	0.000293	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NPS—Alzheimer's disease	1.89e-05	0.000293	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PPP3CA—Alzheimer's disease	1.88e-05	0.000292	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PSEN2—Alzheimer's disease	1.86e-05	0.000289	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—F2—Alzheimer's disease	1.86e-05	0.000289	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTK2B—Alzheimer's disease	1.85e-05	0.000288	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.82e-05	0.000283	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GAB2—Alzheimer's disease	1.8e-05	0.00028	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SST—Alzheimer's disease	1.8e-05	0.00028	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NTRK2—Alzheimer's disease	1.8e-05	0.00028	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CCR5—Alzheimer's disease	1.79e-05	0.000279	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CALM1—Alzheimer's disease	1.79e-05	0.000279	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GSK3A—Alzheimer's disease	1.78e-05	0.000277	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.78e-05	0.000277	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.76e-05	0.000273	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APP—Alzheimer's disease	1.75e-05	0.000273	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PRKCG—Alzheimer's disease	1.72e-05	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NPY—Alzheimer's disease	1.71e-05	0.000266	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—A2M—Alzheimer's disease	1.71e-05	0.000265	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IAPP—Alzheimer's disease	1.7e-05	0.000265	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.7e-05	0.000264	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	1.7e-05	0.000264	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HMOX1—Alzheimer's disease	1.69e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—F2—Alzheimer's disease	1.68e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.68e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PLCB1—Alzheimer's disease	1.66e-05	0.000257	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PSEN2—Alzheimer's disease	1.65e-05	0.000257	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CRH—Alzheimer's disease	1.65e-05	0.000257	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCR5—Alzheimer's disease	1.63e-05	0.000253	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.63e-05	0.000253	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2A—Alzheimer's disease	1.59e-05	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.59e-05	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NPS—Alzheimer's disease	1.57e-05	0.000244	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.56e-05	0.000243	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PPP3CA—Alzheimer's disease	1.56e-05	0.000242	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NGFR—Alzheimer's disease	1.54e-05	0.00024	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—LPL—Alzheimer's disease	1.54e-05	0.00024	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—F2—Alzheimer's disease	1.54e-05	0.000239	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTK2B—Alzheimer's disease	1.54e-05	0.000239	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CREB1—Alzheimer's disease	1.53e-05	0.000239	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.53e-05	0.000238	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	1.52e-05	0.000237	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	1.51e-05	0.000235	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADAM10—Alzheimer's disease	1.51e-05	0.000235	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCL2—Alzheimer's disease	1.5e-05	0.000234	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GAB2—Alzheimer's disease	1.49e-05	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NTRK2—Alzheimer's disease	1.49e-05	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SST—Alzheimer's disease	1.49e-05	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CALM1—Alzheimer's disease	1.49e-05	0.000231	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GSK3A—Alzheimer's disease	1.48e-05	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	1.47e-05	0.000228	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APP—Alzheimer's disease	1.46e-05	0.000226	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	1.45e-05	0.000225	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—S100B—Alzheimer's disease	1.43e-05	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	1.42e-05	0.00022	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.4e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—F2—Alzheimer's disease	1.4e-05	0.000217	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	1.39e-05	0.000216	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MTHFR—Alzheimer's disease	1.39e-05	0.000216	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.38e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PLCB1—Alzheimer's disease	1.37e-05	0.000214	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	1.37e-05	0.000213	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	1.36e-05	0.000212	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF2—Alzheimer's disease	1.36e-05	0.000211	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	1.33e-05	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	1.33e-05	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	1.33e-05	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	1.32e-05	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	1.32e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1R—Alzheimer's disease	1.31e-05	0.000204	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CALM1—Alzheimer's disease	1.3e-05	0.000202	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APOE—Alzheimer's disease	1.29e-05	0.000201	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	1.29e-05	0.000201	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CAV1—Alzheimer's disease	1.28e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	1.28e-05	0.000199	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.28e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	1.27e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LPL—Alzheimer's disease	1.26e-05	0.000196	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	1.25e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MEF2C—Alzheimer's disease	1.25e-05	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	1.25e-05	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	1.24e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PRKCG—Alzheimer's disease	1.22e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	1.22e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NGF—Alzheimer's disease	1.19e-05	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	1.18e-05	0.000184	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.17e-05	0.000183	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.17e-05	0.000183	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCR5—Alzheimer's disease	1.16e-05	0.00018	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	1.14e-05	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	1.14e-05	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	1.13e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	1.13e-05	0.000175	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—Alzheimer's disease	1.13e-05	0.000175	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.13e-05	0.000175	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	1.11e-05	0.000173	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	1.11e-05	0.000172	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—INS—Alzheimer's disease	1.11e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	1.09e-05	0.00017	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.08e-05	0.000169	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.07e-05	0.000167	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.06e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	1.06e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	1.06e-05	0.000164	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	1.06e-05	0.000164	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	1.05e-05	0.000164	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.05e-05	0.000163	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	1.05e-05	0.000163	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	1.04e-05	0.000163	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	1.04e-05	0.000161	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	1.02e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	1.01e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	1e-05	0.000156	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	9.95e-06	0.000155	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	9.9e-06	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	9.74e-06	0.000151	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NOS3—Alzheimer's disease	9.69e-06	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	9.68e-06	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	9.63e-06	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	9.42e-06	0.000147	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.33e-06	0.000145	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	9.28e-06	0.000144	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	9.2e-06	0.000143	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	9.14e-06	0.000142	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	9.11e-06	0.000142	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	9.07e-06	0.000141	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	9.02e-06	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	9.02e-06	0.00014	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	9e-06	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	8.87e-06	0.000138	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—Alzheimer's disease	8.87e-06	0.000138	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	8.79e-06	0.000137	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	8.79e-06	0.000137	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	8.76e-06	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	8.76e-06	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	8.72e-06	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	8.68e-06	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	8.55e-06	0.000133	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	8.53e-06	0.000133	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	8.53e-06	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	8.37e-06	0.00013	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	8.37e-06	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	8.36e-06	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	8.26e-06	0.000128	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	8.08e-06	0.000126	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	7.93e-06	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	7.91e-06	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	7.81e-06	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	7.78e-06	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	7.78e-06	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	7.71e-06	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	7.59e-06	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	7.52e-06	0.000117	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	7.49e-06	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	7.48e-06	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	7.43e-06	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	7.36e-06	0.000114	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.34e-06	0.000114	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	7.34e-06	0.000114	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	7.26e-06	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	7.24e-06	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.18e-06	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	6.77e-06	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	6.74e-06	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	6.71e-06	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	6.68e-06	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	6.67e-06	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	6.65e-06	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	6.56e-06	0.000102	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	6.54e-06	0.000102	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	6.43e-06	0.0001	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	6.25e-06	9.73e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	6.22e-06	9.68e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	6.17e-06	9.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	6.15e-06	9.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	5.83e-06	9.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	5.7e-06	8.86e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LPL—Alzheimer's disease	5.69e-06	8.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	5.62e-06	8.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	5.57e-06	8.66e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	5.53e-06	8.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	5.23e-06	8.13e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	5.13e-06	7.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	5.12e-06	7.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	5.11e-06	7.94e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.99e-06	7.77e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	4.95e-06	7.7e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	4.92e-06	7.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	4.79e-06	7.45e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOE—Alzheimer's disease	4.77e-06	7.42e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	4.73e-06	7.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	4.73e-06	7.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	4.55e-06	7.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	4.54e-06	7.05e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—Alzheimer's disease	4.46e-06	6.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	4.34e-06	6.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	4.3e-06	6.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	4.2e-06	6.53e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	4.16e-06	6.46e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—INS—Alzheimer's disease	4.08e-06	6.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	3.94e-06	6.13e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	3.85e-06	5.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	3.63e-06	5.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	3.58e-06	5.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	3.57e-06	5.56e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	3.27e-06	5.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	3.27e-06	5.08e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	3.17e-06	4.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	3.02e-06	4.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	2.9e-06	4.52e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	2.68e-06	4.17e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.64e-06	2.56e-05	CbGpPWpGaD
